In the pharmaceutical industry, the precision and purity of chemical intermediates are non-negotiable. For manufacturers developing new therapeutic agents or optimizing existing drug formulations, sourcing high-quality raw materials is a critical first step. 3A-Amino-3A-deoxy-beta-cyclodextrin (CAS 117194-77-1) is emerging as a valuable compound in this regard, offering unique properties that can be leveraged in pharmaceutical synthesis and delivery systems.

As a leading manufacturer of fine chemicals in China, we specialize in providing essential intermediates like 3A-amino-3A-deoxy-beta-cyclodextrin. With a confirmed purity of 98%, our product meets the demanding requirements for pharmaceutical applications. The molecule, with its distinct chemical structure (C42H71NO34), is well-suited for various roles within the pharmaceutical value chain, from acting as a building block in complex synthesis to potentially serving as an excipient in drug delivery.

For pharmaceutical procurement managers and R&D scientists, finding a dependable supplier of CAS 117194-77-1 is crucial for supply chain stability. We pride ourselves on being a reliable source for this specialized cyclodextrin derivative, ensuring consistent product quality and availability. Our competitive price for aminodeoxy-beta-cyclodextrin makes it an accessible option for research projects and large-scale manufacturing alike. We understand the importance of timely delivery and are equipped to serve clients globally.

The versatility of 3A-amino-3A-deoxy-beta-cyclodextrin extends to its potential applications in drug solubilization, stabilization, and targeted delivery. These functionalities are highly sought after in the development of more effective and patient-friendly pharmaceutical products. By partnering with us, a reputable China supplier, you gain access to a critical intermediate backed by a commitment to quality and service. We encourage pharmaceutical companies to inquire about our product, request samples, and discuss bulk purchasing to support their ongoing research and production needs.